Nathalie Dubois-Stringfellow insider trades
Open-market stock purchases and sales by Nathalie Dubois-Stringfellow, SVP-CHIEF DEVELOPMENT OFFICER at Sangamo Therapeutics, Inc, from SEC Form 4 filings since Feb 24, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 25, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $703 |
| Apr 21, 2026 | SGMO Sangamo Therapeutics, Inc | Sold | $89.2K |
| Apr 1, 2026 | SGMO Sangamo Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $5.8K |
| Feb 24, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $975 |
| Jan 22, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $14.6K |
| Nov 24, 2025 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $1.1K |
Companies traded
- SGMO Sangamo Therapeutics, Inc: 1 sale, last May 25, 2026
Get free alerts when Nathalie Dubois-Stringfellow files a new trade →